Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iTOF: ICG in Oesophageal Atresia Repair
NCT05735964Recruiting
- Sponsor
- Birmingham Women's and Children's NHS Foundation Trust
- Start
- Mar 2023
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of indocyanine green in esophageal atresia (EA) and tracheoesophageal fistula (TEF), sponsored by Birmingham Women's and Children's NHS Foundation Trust. Primary endpoints: Intravenous ICG Perfusion Assessment and Enteral ICG Leak Assessment. Started Mar 2023; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
esophageal atresia (EA)tracheoesophageal fistula (TEF)
Beyond the preview
Go deeper on NCT05735964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05735964.